(Alliance News) - The following is a round-up of updates by London-listed companies, issued this week and not separately reported by Alliance News: Read More
LONDON BROKER RATINGS: Jefferies cuts Berkeley, Barratt and Bellway Read More
Study shows potential for Angle's Parsortix system in clinical trials Read More
Angle says Parsortix system could replace cancer tissue biopsy Read More
Angle cancer study delayed as accreditation process for labs starts Read More
TRADING UPDATES: Harvest Minerals sales jump; Quartix earnings to rise Read More
EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair Read More
Angle first-half loss widens, crucial FDA decision expected this year Read More
IN BRIEF: Angle notes studies supporting Parsortix system in cancer Read More
UK earnings, trading statements calendar - next 7 days Read More
IN BRIEF: Angle's Parsortix used in Spanish study to find cancer Read More
IN BRIEF: Angle's Parsortix enables gene analysis in cancer study Read More
TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million Read More
TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident Read More
IN BRIEF: Angle's Parsortix successfully used to harvest cancer cells Read More
IN BRIEF: Angle raises GBP20.0 million to fund FDA approval drive Read More
IN BRIEF: Angle to raise GBP20 million through shares placing Read More
UK shareholder meetings calendar - next 7 days Read More
TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit Read More
IN BRIEF: Angle responds to additional information request from US FDA Read More
